Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Özlem Kurt Azap et al.|The Lancet Infectious Diseases|2017Cited by 521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Enrico Maria Trecarichi et al.|Clinical Infectious Diseases|2018Cited by 351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective surveyEnrico Maria Trecarichi, M. Tumbarello, Livio Pagano et al.|Clinical Microbiology and Infection|2014Cited by 241
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B RegistryLivio Pagano, Morena Caira, Anna Candoni et al.|Clinical Infectious Diseases|2012Cited by 83